Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Voices From The Bench: Supreme Court Justices Probe The Affordable Care Act

Executive Summary

“The Pink Sheet” highlights intriguing, and perhaps telling, comments by U.S. Supreme Court justices from three days of oral arguments pertaining to the constitutionality of the Affordable Care Act, including the constitutionality of the “individual mandate” for insurance coverage, its severability from other ACA provisions, and whether new Medicaid requirements are an unconstitutional coercion of the states.

You may also be interested in...



The Law That Almost Wasn’t: Affordable Care Act and the Supreme Court

The Supreme Court’s decision to uphold the constitutionality of the Affordable Care Act came as a surprise to most legal experts. But as Jeffrey Toobin writes in his new book on the Supreme Court, Chief Justice John Roberts saved the high court’s reputation – and his own – by allowing the majority of President Obama’s health care law to remain intact.

Did PDUFA V Pass Too Quickly?

The pending Supreme Court decision on the Affordable Care Act may have forced negotiators to finish quicker than they would have liked as legislators indicate some more time may have produced an agreement on track-and-trace standards; stakeholders may question whether the bill could have been improved had the deadline not been looming.

Cost Containment, Payer Consolidation Are Irreversible – But Opportunities, Private Equity Investors Say

Whether or not the Affordable Care Act survives a Supreme Court review, private equity investors see abundant opportunities in the rapidly reforming U.S. healthcare landscape, although buyers’ and sellers’ different views of the future lead to pricing disparities.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS054350

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel